Title(s):
Associate Professor of Radiation Oncology and Molecular Radiation Sciences
Associate Professor of Oncology
Associate Professor of Oncology
Appointment Phone:
410-502-8000
Primary Location:
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Expertise:
Breast Cancer, Cervical Cancer, Endometrial Cancer, Gynecologic Cancers, Radiation Oncology
Education and Experience
Training
- Johns Hopkins University School of Medicine (Baltimore MD)/ (1991)
Residencies
- University of Michigan Health System (Ann Arbor MI)/ Radiation Oncology (1996)
Certifications
- Radiation Oncology, American Board of Radiology (2006)
Locations
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
401 N. Broadway
Baltimore, MD 21231
Phone: 410-502-1421
Appointment Phone: 410-502-8000
Fax: 410-502-1419
Location Map
Johns Hopkins Medicine - Green Spring Station
10753 Falls Road
Pavilion II
Baltimore, MD 21093
Phone: 410-502-8001
Appointment Phone: 410-502-8001
Location Map
Department / Division
- Radiation Oncology and Molecular Radiation Sciences
Centers/Institutes
Centers / Institutes
- Avon Foundation Breast Center
- Sidney Kimmel Comprehensive Cancer Center
Bio
Biography
Dr. Richard C. Zellars is an Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and in the Department of Oncology. He is a graduate of the Johns Hopkins School of Medicine and completed his residency in Radiation Oncology at the University of Michigan.
Previous appointments include Assistant Professorship in the Department of Radiation Medicine at Georgetown University Medical Center and Vice Chairmanship of the Department of Radiation Oncology at the University of Texas at San Antonio. Dr. Zellars primary clinical and research interests are in the treatment of Breast and Gynecologic cancers. He has received several grants to perform research in the treatment of breast cancer. Presently he is enrolling patients into a partial breast irradiation and concurrent chemotherapy trial of his design. This clinical trial decreases the duration of standard breast cancer therapy (chemotherapy followed by radiation after lumpectomy) from 5-6 months to less than 2 months.
Previous appointments include Assistant Professorship in the Department of Radiation Medicine at Georgetown University Medical Center and Vice Chairmanship of the Department of Radiation Oncology at the University of Texas at San Antonio. Dr. Zellars primary clinical and research interests are in the treatment of Breast and Gynecologic cancers. He has received several grants to perform research in the treatment of breast cancer. Presently he is enrolling patients into a partial breast irradiation and concurrent chemotherapy trial of his design. This clinical trial decreases the duration of standard breast cancer therapy (chemotherapy followed by radiation after lumpectomy) from 5-6 months to less than 2 months.
Expertise
- Breast Cancer
- Cervical Cancer
- Endometrial Cancer
- Gynecologic Cancers
- Radiation Oncology
Research
Research and Publications
Ford, E.C.; Lavely, W.C.; Frassica, D.A.; Myers, L.T.; Asrari, F.; Wahl, R.L.; Zellars, R.C. Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):595-602.
Balmanoukian, A.; Zhang, Z.; Jeter, S.; Slater, S.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Wolff, A.C.; Davidson, N.E.; Jacobs, L.; Lange, J.; Tsangaris, T.N.; Zellars, R.; Gabrielson, E.; Stearns, V. African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. J Clin Oncol. 2009 Aug 1;27(22):e35-37; author reply e38-39.
Ford, E.C.; Gaudette, R.; Myers, L.; Vanderver, B.; Engineer, L.; Zellars, R.; Song, D.Y.; Wong, J.; Deweese, T.L. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):852-858.
Zellars, R.C. Deemphasize dogma: consider the local control-overall survival link. Oncology (Williston Park). 2009 Jul;23(8):679-680.
Zellars, R.C.; Stearns, V.; Frassica, D.; Asrari, F.; Tsangaris, T.; Myers, L.; DiPasquale, S.; Lange, J.R.; Jacobs, L.K.; Emens, L.A.; Armstrong, D.K.; Fetting, J.H.; Garrett-Mayer, E.; Davidson, N.E.; Wolff, A.C. Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. J Clin Oncol. 2009 Jun 10;27(17):2816-2822.
Chumsri, S.; Jeter, S.; Jacobs, L.K.; Nassar, H.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Lange, J.R.; Riley, C.; Tsangaris, T.N.; Wolff, A.C.; Zellars, R.; Zhang, Z.; Stearns, V. Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer. Clin Breast Cancer. 2010 Feb;10(1):40-45.
Ford, E.C., Lavely, W.C., Frassica, D.A., Myers, L.T., Asrari, F., Wahl, R.L., and Zellars, R.C. (2008). Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation. Int J Radiat Oncol Biol Phys 71, 595-602.
Zellars, R.C., Stearns, V., Frassica, D., Asrari, F., Tsangaris, T., Myers, L., DiPasquale, S., Lange, J., Jacobs, L., Emens, L.A., Armstrong, D., Fetting, J., Garrett-Mayer, E., Davidson, N.E. and Wolff, A.C. (2009). Feasibility Trial of Partial Breast Irradiation with Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early Stage Breast Cancer. J Clin Onc 27, 2816-2822.
Balmanoukian, A.; Zhang, Z.; Jeter, S.; Slater, S.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Wolff, A.C.; Davidson, N.E.; Jacobs, L.; Lange, J.; Tsangaris, T.N.; Zellars, R.; Gabrielson, E.; Stearns, V. African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. J Clin Oncol. 2009 Aug 1;27(22):e35-37; author reply e38-39.
Ford, E.C.; Gaudette, R.; Myers, L.; Vanderver, B.; Engineer, L.; Zellars, R.; Song, D.Y.; Wong, J.; Deweese, T.L. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):852-858.
Zellars, R.C. Deemphasize dogma: consider the local control-overall survival link. Oncology (Williston Park). 2009 Jul;23(8):679-680.
Zellars, R.C.; Stearns, V.; Frassica, D.; Asrari, F.; Tsangaris, T.; Myers, L.; DiPasquale, S.; Lange, J.R.; Jacobs, L.K.; Emens, L.A.; Armstrong, D.K.; Fetting, J.H.; Garrett-Mayer, E.; Davidson, N.E.; Wolff, A.C. Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. J Clin Oncol. 2009 Jun 10;27(17):2816-2822.
Chumsri, S.; Jeter, S.; Jacobs, L.K.; Nassar, H.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Lange, J.R.; Riley, C.; Tsangaris, T.N.; Wolff, A.C.; Zellars, R.; Zhang, Z.; Stearns, V. Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer. Clin Breast Cancer. 2010 Feb;10(1):40-45.
Ford, E.C., Lavely, W.C., Frassica, D.A., Myers, L.T., Asrari, F., Wahl, R.L., and Zellars, R.C. (2008). Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation. Int J Radiat Oncol Biol Phys 71, 595-602.
Zellars, R.C., Stearns, V., Frassica, D., Asrari, F., Tsangaris, T., Myers, L., DiPasquale, S., Lange, J., Jacobs, L., Emens, L.A., Armstrong, D., Fetting, J., Garrett-Mayer, E., Davidson, N.E. and Wolff, A.C. (2009). Feasibility Trial of Partial Breast Irradiation with Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early Stage Breast Cancer. J Clin Onc 27, 2816-2822.
Research Interests
- Breast Cancer
More Info
Languages
- English
Clinical Trials
- breast cancer
Additional Resources
Johns Hopkins Radiation Oncology and Molecular Sciences
Johns Hopkins Breast Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Johns Hopkins Breast Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Videos and Podcasts
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts